Tolerance induction by CD40 blocking through specific antibody in dendritic cells

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 3, 2010, Pages 141-147

  Karimi, Mohammad Hossein ^a   Ebadi, Padideh ^b   Pourfathollah, Ali Akbar ^c   Moazzeni, Seyed Mohammad ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

CD40; Dendritic cell; Tolerance induction

Indexed keywords

ALLOANTIGEN; BLOCKING ANTIBODY; CD40 ANTIBODY; CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 12; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TH2 CELL; ANIMAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; ANTIGENS, CD40; DENDRITIC CELLS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 78049462328     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381:434-8. (Pubitemid 26162734)
2. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92:9560-4.
3. Rigby MR, Trexler AM, Pearson TC, Larsen CP. CD28/CD154 blockade prevents autoimmune diabetes by inducing non deletional tolerance after effector T-cell inhibition and regulatory T-Cell expansion. Diabetes 2008; 57(10):2672-83.
4. Ma DY, Clark EA. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 2009; 21:265-72.
5. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I,et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180:1263-72. (Pubitemid 24289600)
6. Pinchuk LM, Polacino PS, Agy MB, Klaus SJ, Clark EA. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1994; 1(4):317-25.
7. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367:425-8.
8. Zhai Y, Kupiec-Weglinski JW. The CD154-CD40 costimulation pathway in organ transplantation. Transplant Rev 2004; 18(1):10-9. (Pubitemid 38744801)
9. Munroe ME, Bishop GA. A co stimulatory function for T cell CD40.J Immunol 2007; 178:671-82.
10. Li XL, Ménoret S, Le Mauff B, Angin M, Anegon I. Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation. Transplantation 2008; 86(1):10-5.
11. Reise Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006; 6(6):476-83.
12. Karimi MH, Ebadi P, Pourfathollah AA, Soheili ZS, Samiee Sh, Ataee Z, et al. Immune modulation through RNA interference-mediated silencing of CD40 in dendritic cells. Cell Immunol 2009; 259(1):74-81.
13. Min WP, Gorczynski R, Huang XY, Kushida M, Kim P, Obatakil M, et al. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol 2000; 164(1):161-7. (Pubitemid 30012986)
14. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70:83-243. (Pubitemid 128678837)
15. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392(6673):245-52.
16. Siwkowski AM, Malik L, Esau CC, Maier MA, Wancewicz EV, Albertshofer K, et al. Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Research 2004; 32(9):2695-706. (Pubitemid 38885941)
17. Lu L, Rudert WA, Qian S, McCaslin D, Fu F, Rao AS, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995; 182(2):379-87.
18. Sun W, Wang Q, Zhang L, Liu L, Zhang M, Wang C, et al. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen4 immunoglobulin. Transplantation 2003; 76(9):1351-9. (Pubitemid 37430723)
19. Buhlmann JE, Foy TM, Aruffo A, Crassi KM, Ledbetter JA, Green WR, et al. In the absence of CD40 signal, B cells are tolerogenic. Immunity 1995; 2(6):645-53.
20. Vincenti F. Co stimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008; 121(2):299-306.
21. Karimi MH, Ebadi P, Pourfathollah AA, Soheili ZS, Samiee Sh, Ataee Z, et al. Tolerance induction by CD40 silenced Dendritic cells through antisense. Iran Red Cres Med J 2009; 11:1-9.
22. Kohka H, Iwagaki H, Yoshino T, Kobashi K, Urushihara N, Yagi T, et al. Involvement of interleukin-18 (IL-18) in mixed lymphocyte reactions (MLR). J Interferon Cytokine Res 1999; 19(9):1053-7. (Pubitemid 29445063)
23. Tadmori W, Zhang M, Beavis AJ, Sullivan LM, Narula SK. Suppression of the allogeneic response by human IL-10: a critical role for suppression of a synergy between IL-2 and TNF-α. Cytokine 1994; 6(5):462-71. (Pubitemid 24306959)
24. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178(3):1041-8. (Pubitemid 23260442)
25. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3(12):984-93.
26. Haase C, Michelsen, BK, Jorgensen TN. CD40 is necessary for activation of naive T cells by a dendritic cell line in vivo but not in vitro. Scand J Immunol 2004; 59(3):237-45. (Pubitemid 38429289)
27. Cong Y, Weaver CT, Lazenby A, Elson CO. Colitis induced by enteric bacterial antigen-specific CD4 T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12. J Immunol 2000; 165(4):2173-82. (Pubitemid 30643167)
28. Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40-CD40L co stimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002; 99(12):4601-9. (Pubitemid 34627233)
29. Zhang L, Procuik M, Fang T, Kang SK. Functional analysis of the quantitative expression of a co stimulatory molecule on dendritic cells using lentiviral vector-mediated RNA interference. J Immunol Methods 2009; 344(2):87-97.
30. Li L, Wang H, Wang B. Anergic cells generated by blocking CD28 and CD40 costimulatory pathways in vitro ameliorate collagen induced arthritis. Cell Immunol 2008; 254(1):39-45.
31. Luo Z, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, et al. Anergic T cells generated in vitro suppress rejection response to islet allografts. Transplantation 2000; 69(10):2144-8. (Pubitemid 30395051)